Companies / Canada
Sanofi-Aventis Facing Dual Patent Challenge
August 2006 | Legal NewsFrench firm Sanofi-Aventis is heading for an uncertain financial future as its two best-selling drugs face generic competition in the US for the first time.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
